Page last updated: 2024-12-06

10-undecynoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

10-Undecynoic acid is a long-chain fatty acid with a terminal alkyne group. It is a naturally occurring compound found in some plants and has attracted attention for its potential applications in various fields.
Its synthesis involves several steps, including the reaction of 1-bromo-10-undecyne with magnesium to form a Grignard reagent, followed by reaction with carbon dioxide.
10-undecynoic acid exhibits biological activities, including anti-inflammatory and anti-tumor effects.
It is also a precursor for the synthesis of various useful compounds, such as polymers, pharmaceuticals, and agrochemicals.
Due to its unique structural features, 10-undecynoic acid is studied for its potential in areas like materials science, medicine, and agriculture.
Further research is ongoing to explore its full potential and develop new applications.'

10-undecynoic acid: inhibitor of lauric acid monooxygenase; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID31039
CHEBI ID185054
SCHEMBL ID40510
MeSH IDM0139026

Synonyms (31)

Synonym
10-undecynoic acid
undec-10-ynoic acid
LMFA01030618
10-undecynoic acid, 95%
2777-65-3
brn 1704918
hendecynoic acid
einecs 220-471-8
AKOS001592014
U0054
CHEBI:185054
GEO-02443
2f79g7h1wy ,
4-02-00-01738 (beilstein handbook reference)
unii-2f79g7h1wy
FT-0607205
10-hendecynoic acid
SCHEMBL40510
undec-1-yn-11-oic acid
W-200273
DTXSID2075219
mfcd00014389
J-802018
AT18751
undec-10-ynoicacid
STL554898
Q18611669
AS-57177
LCZC1163
CS-0160163
SY048514
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
medium-chain fatty acidAny fatty acid with a chain length of between C6 and C12.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (35.71)18.7374
1990's2 (14.29)18.2507
2000's5 (35.71)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.06 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index25.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]